Point Biopharma
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), manufacturing technology and novel direct-to-patient targeting to revolutionize theragnostic drug development and radioligand commercialization.
Domain
pointbiopharma.com
Country
United StatesIndustry
BiopharmaEmployees
51-100
Last Funding
$125.0M
Founded
2016
Tech Stack (9 technologies)
Frequently Asked Questions
What technologies does Point Biopharma use?+
Point Biopharma uses 9 technologies including Adobe Client Data Layer, Adobe Experience Manager Franklin, Adobe Experience Platform Launch.
What industry is Point Biopharma in?+
Point Biopharma operates in the Biopharma industry.
Where is Point Biopharma based?+
Point Biopharma is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026